ImmunologybioRxivPreprint
Lactose and its derivatives are a new class of immune checkpoint inhibitors for cancer therapy
Hong H. Yu, Xiaofang Si, Wenjing Liu…·Yu Zhang
This study identifies lactose and its derivatives as immune checkpoint inhibitors by enhancing CD8+ T-cell function through modulation of galactosylation and Gal-1 interactions.
1 citation